Meet Dr Robert Mamoun CEO/CSO of Ciloa at BIO 2014 on June 23-26th 2014. Ciloa’s technology produces fully native membrane proteins (GPCRs, Kinase Receptors, Ion channels, viral proteins, Ig superfamily, etc.) out of cells on exosomes. The use of potent adjuvant properties of exosomes allows to develop vaccine and antibodies against these challenging targets.
- Mamoun will present on Fast-track “R&D partnering with France” on June 23th 2014.
Schedule for One-on-One Partnering or meet him at French pavilion (booth # 2917) to know more on Ciloa’s technology.
